Immunotec Inc (IMMTF) 0.2285 $IMMTF
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 43.83 (-0.86), AVP: 7.90 (-0.15), NUS: 60.76 (-0.14), LFVN: 0.69 (+0.02)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com.
IMM.VN: 0.285 (+0.020)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.285 (+0.020)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015.
IMM.VN: 0.285 (+0.020)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.285 (+0.020)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec" and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life.
IMM.VN: 0.285 (+0.020)
Immunotec Celebrates a Fourth Anniversary in Mexico and Announces the Appointment of a New Director
Marketwired - Thu Oct 30, 3:48PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced the appointment of a new director and celebration of the fourth anniversary of its presence in Mexico.
IMM.VN: 0.285 (+0.020)
Immunotec Opens New Sales Office in Commerce, California, U.S.A.
Marketwired - Tue Oct 21, 8:17PM CDT
Immunotec Inc. (TSX VENTURE: IMM) is proud to announce the opening of its new Sales Office in Commerce, California, U.S.A. With the considerable growth of Independent Distributors and increased sales throughout the southwestern region of the United States of America, a greater need for support of the regional Independent Distributors has become apparent. As a result, Immunotec has opened a 7,200 square foot full-service sales facility that is equipped to meet the needs of the Independent Distributors. The office officially opened for business on Monday, October 20, 2014.
IMM.VN: 0.285 (+0.020)
Immunotec Inc.: Immunocal(R) Used in Novel Prehabilitation Study
Marketwired - Tue Oct 14, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry announces the completion of a first research collaboration with Dr. Franco Carli MD, MPh, Anesthesiologist at the McGill University Health Centre (MUHC), Montreal, Quebec, Canada. Immunocal(R) was used as part of the trimodal intervention Prehabilitation study sponsored by MUHC with support provided by the Montreal General Hospital Foundation and the Perioperative Program (POP).The results of this study were published electronically in the July 29, 2014 issue of Anesthesiology(1) and most recently presented at the American Congress of Rehabilitation Medicine (ACRM) 91st Annual Conference 'Progress in Rehabilitation Research' held in Toronto on October 7-11, 2014.
IMM.VN: 0.285 (+0.020)
Immunotec Announces Third Quarter 2014 Results
Marketwire - Mon Sep 29, 6:11PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", released results for the three- and nine-month periods ending on 31 July 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.285 (+0.020)
Herbalife: The Eve Of Destruction
Rogier van Vlissingen - at Seeking Alpha - Thu Mar 26, 11:14AM CDT
HLF: 43.83 (-0.86), AVP: 7.90 (-0.15), NUS: 60.76 (-0.14), LFVN: 0.69 (+0.02)
Immunotec Reports Results of its Annual General and Special Meeting of Shareholders
Marketwired - Fri Mar 20, 3:19PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General and Special Meeting of Shareholders held on March 17, 2015 ("AGM". During the AGM, all current directors of the Company were re-elected, PricewaterhouseCoopers LLP was reappointed as the Company's auditor and the new Management Incentive Plan ("MIP" announced on February 18, 2015 was approved by disinterested shareholders. Three million common shares of the Company (the "Shares" are reserved and authorized for future issuance under this MIP. The full text of the MIP appears in the Company's Management Proxy Circular filed on February 19, 2015 on SEDAR and may be consulted at www.sedar.com. IMM.VN: 0.285 (+0.020)
Immunotec Reports First Quarter Results
Marketwired - Tue Mar 17, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the first quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.285 (+0.020)
Immunotec Announces Proposed Management Incentive Plan
Marketwired - Wed Feb 18, 3:49PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct- to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced the terms of its new Management Incentive Plan ("MIP". This MIP will be submitted to the Company's shareholders for approval at the upcoming Annual and Special Meeting of Shareholders to be held on March 17, 2015. IMM.VN: 0.285 (+0.020)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.285 (+0.020)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec"
and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life. IMM.VN: 0.285 (+0.020)
Immunotec Celebrates a Fourth Anniversary in Mexico and Announces the Appointment of a New Director
Marketwired - Thu Oct 30, 3:48PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced the appointment of a new director and celebration of the fourth anniversary of its presence in Mexico. IMM.VN: 0.285 (+0.020)
Immunotec Opens New Sales Office in Commerce, California, U.S.A.
Marketwired - Tue Oct 21, 8:17PM CDT
Immunotec Inc. (TSX VENTURE: IMM) is proud to announce the opening of its new Sales Office in Commerce, California, U.S.A. With the considerable growth of Independent Distributors and increased sales throughout the southwestern region of the United States of America, a greater need for support of the regional Independent Distributors has become apparent. As a result, Immunotec has opened a 7,200 square foot full-service sales facility that is equipped to meet the needs of the Independent Distributors. The office officially opened for business on Monday, October 20, 2014.
IMM.VN: 0.285 (+0.020)
Immunotec Inc.: Immunocal(R) Used in Novel Prehabilitation Study
Marketwired - Tue Oct 14, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry announces the completion of a first research collaboration with Dr. Franco Carli MD, MPh, Anesthesiologist at the McGill University Health Centre (MUHC), Montreal, Quebec, Canada. Immunocal(R) was used as part of the trimodal intervention Prehabilitation study sponsored by MUHC with support provided by the Montreal General Hospital Foundation and the Perioperative Program (POP).The results of this study were published electronically in the July 29, 2014 issue of Anesthesiology(1) and most recently presented at the American Congress of Rehabilitation Medicine (ACRM) 91st Annual Conference 'Progress in Rehabilitation Research' held in Toronto on October 7-11, 2014.
IMM.VN: 0.285 (+0.020)
Immunotec Announces Third Quarter 2014 Results
Marketwire - Mon Sep 29, 6:11PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, released results for the three- and nine-month periods ending on 31 July 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.285 (+0.020)
